Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldstein

Showing results (261-270 of 518) with videos related to

Pageof 52
Sort By:
JNCI Cancer Spectrum|June 2, 2025
INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curseYu Yang Soon, Katrin Sjoquist, Ian C Marschner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2015
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)David Goldstein, Daniel D Von Hoff, Malcolm Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Cancer patient preferences for communication of prognosis in the metastatic settingRebecca G Hagerty, Phyllis N Butow, Peter A Ellis, et al.
JCO Global Oncology|September 19, 2025
Understanding Barriers to Clinical Cancer Research in the Asia-PacificRashid N Lui, Jimmy Billod, Sophia Frentzas, et al.
Plos One|January 27, 2017
Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral NeuropathyPreet G S Makker, Samuel S Duffy, Justin G Lees, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 4, 2017
Anxiety, depression and quality of life in people with pancreatic cancer and their carersMonika Janda, Rachel E Neale, Kerenaftali Klein, et al.
Cancers|July 2, 2021
HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic CancerTony C Y Pang, Zhihong Xu, Alpha Raj Mekapogu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Genetic polymorphisms and head and neck cancer outcomes: a reviewJessica Hopkins, David W Cescon, Darren Tse, et al.
Oral Oncology|February 22, 2021
Effect of age and gender in non-smokers with oral squamous cell carcinoma: Multi-institutional studyLawrence J Oh, Rebecca Asher, Michael Veness, et al.
JNCI Cancer Spectrum|June 23, 2021
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon CancerPrunella Blinman, Andrew Martin, Michael Jefford, et al.
Pageof 52

Showing results (261-270 of 518) with videos related to

Sort By:
Pageof 52
JNCI Cancer Spectrum|June 2, 2025
INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curseYu Yang Soon, Katrin Sjoquist, Ian C Marschner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2015
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)David Goldstein, Daniel D Von Hoff, Malcolm Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Cancer patient preferences for communication of prognosis in the metastatic settingRebecca G Hagerty, Phyllis N Butow, Peter A Ellis, et al.
JCO Global Oncology|September 19, 2025
Understanding Barriers to Clinical Cancer Research in the Asia-PacificRashid N Lui, Jimmy Billod, Sophia Frentzas, et al.
Plos One|January 27, 2017
Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral NeuropathyPreet G S Makker, Samuel S Duffy, Justin G Lees, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 4, 2017
Anxiety, depression and quality of life in people with pancreatic cancer and their carersMonika Janda, Rachel E Neale, Kerenaftali Klein, et al.
Cancers|July 2, 2021
HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic CancerTony C Y Pang, Zhihong Xu, Alpha Raj Mekapogu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Genetic polymorphisms and head and neck cancer outcomes: a reviewJessica Hopkins, David W Cescon, Darren Tse, et al.
Oral Oncology|February 22, 2021
Effect of age and gender in non-smokers with oral squamous cell carcinoma: Multi-institutional studyLawrence J Oh, Rebecca Asher, Michael Veness, et al.
JNCI Cancer Spectrum|June 23, 2021
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon CancerPrunella Blinman, Andrew Martin, Michael Jefford, et al.
Pageof 52